Political Handbook of the World annually provides up-to-date political information on all the world's countries in a balanced, accurate and comprehensive manner. A singular and authoritative reference work for nearly 70 years, each new volume builds on the research and scholarship of previous editions, offering rare insight into stories making headlines, judiciously outlining contemporary conflicts and analysing current foreign policy within the informed context of past events and decisions. It is considered to be the single-volume reference work of choice for libraries, diplomats, academic faculties, international corporations, and others needing accurate, timely information.
This title was first published in 2001. A discussion of managerial, occupational and organizational stress research. The volume is in seven parts. The first part explores the theoretical or conceptual frameworks in occupational and organizational stress that have developed out of empirical work and work with others in different countries. The second part provides the reader with reviews of literature on different topics in the field of workplace stress. Part Three highlights a range of studies undertaken by UMIST and their collaborating colleagues in different institutions. The research that highlights issues and problems of current relevance is found in the fourth part, while the methodological studies involving instrument development, refining of existing measures, and more, is found in Part Five. The studies linking stress and health follows on from this, and the new area of investigation, evaluating stress management interventions, concludes this survey of research in this field.
This work covers the latest developments in food safety and foodborne illness, organizing information to provide easy access to hundreds of topics, both general and specific. Comprehensive summaries of the most important advances in food science, complied from over 580 sources worldwide, are included. Health and safety, including extensive reviews of microbiology and medical subjects, is highlighted.
How can biological markers help assess and predict human health risks? Find out the answers to this question and others in this timely new book examining the use of biological markers in animals and plants for evaluating the ecological and health effects of environmental contamination. The book explains the concept of environmental sentinels, presents example of field studies and discusses the utility of biomarkers within a risk analysis paradigm. Anyone who needs to know how to assess and predict environmental contamination should consider this book essential reading.
Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.; A highly original combination of philosophical rigour, historical sensitivity and empirical depth enables the "black box" of industrial and government science to be opened up to critical scrutiny much more than in previous social scientific study. All major aspects of drug testing and regulation are considered, including pre- clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions. The author argues that drug regulators are too dependent on pharmaceutical industry resources and expertise, and too divorced from public accountability. The problem of corporate bias is particularly severe in the UK, where regulatory decisions about medicine safety are shrouded in greater secrecy than in the US.; Since the purpose of drug regulation should be to maximize the safety and effectiveness of medicines for patients, the public needs and deserves policies to counteract corporate bias in drug testing and evaluation. John Abraham's realist analysis provides a robust basis for policy interventions at the institutional and legislative levels. He proposes that corporate bias could be reduced by more extensive freedom of information, greater autonomy of government scientists from pharmaceutical industry, the development of independent drug testing by the regulatory authority, increased patient representation on regulatory committees, and more frequent and thorough oversight of regulatory performance by the legislature. This book should be of interest to anyone who cares about how medicines should be controlled in modern society. It should prove particularly rewarding for students and researchers in the sociology of science and technology, science and medicines policy, medical sociologists, the medical and pharmaceutical professions, and consumer organizations.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.